U.S. biotech financing drops 46% in Q1 compared to 2021
Venture financing deal value for U.S.-headquartered biotech companies dipped by 46% in Q1 2022 compared…
Venture financing deal value for U.S.-headquartered biotech companies dipped by 46% in Q1 2022 compared…
European investment company Gimv has launched its fifth investment platform with a focus on venture…
Biotech investments in Europe jumped in May 2022 with a large initial public offering from…
As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a…
After gathering huge investment funds in 2021, European biotech investors took a breather in the…
Big European venture capital firms Jeito, Forbion, and Inkef Capital have teamed up to propel…
More than a year after biotech stock indices peaked, the markets are worse than ever.…
The European life sciences venture capital firm Sofinnova Partners is celebrating its 50th birthday this…
As US and European investor interest in Japanese biopharma startups spikes, the Belgian venture capital…
The US venture capital firm Apple Tree Partners (ATP) is making its first transatlantic foray…
The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health…
The takeover of the Spanish firm Sanifit by Vifor Pharma in Switzerland marks a high…